Article
FcgammaRIIIa polymorphisms and cetuximab induced cytotoxicity in squamous cell carcinoma of the head and neck.
Cancer immunology, immunotherapy : CII - 1 Jul 2009
Taylor Rodney J, Chan Siaw-Lin, Wood Aaron, Voskens Caroline J, Wolf Jeffrey S, Lin Wei, Chapoval Andrei, Schulze Dan H, Tian Guoliang, Strome Scott E
Abstract excerpt
PURPOSE: The interaction of Fc fragments of antibodies with the Fcgamma receptors is an essential checkpoint in antibody-dependent cellular cytotoxicity (ADCC). Specific polymorphisms at position 158 enhance FcgammaRIIIa affinity for IgG1 and are associated with improved clinical outcome in lymphoma patients treated with IgG1 anti-CD20 antibody. The role of ADCC in the therapeutic effects of the alpha-epidermal...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
